182 related articles for article (PubMed ID: 16409766)
1. [The role of specific ROCK inhibitor in the prevention of experimental PVR in rabbits].
Zheng YP; Sun NX; Xiong QC; Quan YL; Wang F
Zhonghua Yan Ke Za Zhi; 2005 Dec; 41(12):1112-8. PubMed ID: 16409766
[TBL] [Abstract][Full Text] [Related]
2. Involvement of rho-kinase pathway in contractile activity of rabbit RPE cells in vivo and in vitro.
Zheng Y; Bando H; Ikuno Y; Oshima Y; Sawa M; Ohji M; Tano Y
Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):668-74. PubMed ID: 14744913
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
4. Critical role of the Rho-kinase pathway in TGF-beta2-dependent collagen gel contraction by retinal pigment epithelial cells.
Miura M; Hata Y; Hirayama K; Kita T; Noda Y; Fujisawa K; Shimokawa H; Ishibashi T
Exp Eye Res; 2006 May; 82(5):849-59. PubMed ID: 16310190
[TBL] [Abstract][Full Text] [Related]
5. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
[TBL] [Abstract][Full Text] [Related]
6. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
[TBL] [Abstract][Full Text] [Related]
7. Effect of 2'-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model.
Lee JJ; Park JK; Kim YT; Kwon BM; Kang SG; Yoo YD; Yu YS; Chung H
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3117-24. PubMed ID: 12202537
[TBL] [Abstract][Full Text] [Related]
8. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
9. Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy.
Guo L; Yu W; Li X; Zhao G; Liang J; He P; Wang K; Zhou P; Jiang Y; Zhao M
Exp Eye Res; 2008 Dec; 87(6):551-60. PubMed ID: 18926819
[TBL] [Abstract][Full Text] [Related]
10. Effects of topoisomerase II inhibitors on retinal pigment epithelium and experimental proliferative vitreoretinopathy.
Kuo HK; Wu PC; Yang PM; Chen YH; Wu YC; Hu DN
J Ocul Pharmacol Ther; 2007 Feb; 23(1):14-20. PubMed ID: 17341145
[TBL] [Abstract][Full Text] [Related]
11. The activation of MEK-ERK1/2 by glutamate receptor-stimulation is involved in the regulation of RPE proliferation and morphologic transformation.
Pacheco-Domínguez RL; Palma-Nicolas JP; López E; López-Colomé AM
Exp Eye Res; 2008 Feb; 86(2):207-19. PubMed ID: 18061165
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PVR with a tyrosine kinase inhibitor, dasatinib, in the swine.
Umazume K; Liu L; Scott PA; de Castro JP; McDonald K; Kaplan HJ; Tamiya S
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1150-9. PubMed ID: 23341014
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
[TBL] [Abstract][Full Text] [Related]
14. [Changes of protein kinase C for the proliferation of retinal pigment epithelium cells induced by subretinal fluid].
Sun ZY; Hong J
Zhonghua Yan Ke Za Zhi; 2006 Aug; 42(8):738-43. PubMed ID: 17081448
[TBL] [Abstract][Full Text] [Related]
15. ROCK inhibition with Y27632 activates astrocytes and increases their expression of neurite growth-inhibitory chondroitin sulfate proteoglycans.
Chan CC; Wong AK; Liu J; Steeves JD; Tetzlaff W
Glia; 2007 Mar; 55(4):369-84. PubMed ID: 17136770
[TBL] [Abstract][Full Text] [Related]
16. siRNA targeting mammalian target of rapamycin (mTOR) attenuates experimental proliferative vitreoretinopathy.
Zhou P; Zhao MW; Li XX; Yu WZ; Bian ZM
Curr Eye Res; 2007 Nov; 32(11):973-84. PubMed ID: 18027173
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotide targeting c-fos mRNA limits retinal pigment epithelial cell proliferation: a key step in the progression of proliferative vitreoretinopathy.
Zhang L; Li X; Zhao M; He P; Yu W; Dong J; Liu G; Li C; Shi X
Exp Eye Res; 2006 Dec; 83(6):1405-11. PubMed ID: 16973160
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
Yan F; Hui YN; Li YJ; Guo CM; Meng H
Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbits.
Yu HG; Chung H
Korean J Ophthalmol; 1997 Dec; 11(2):98-105. PubMed ID: 9510652
[TBL] [Abstract][Full Text] [Related]
20. Attenuated glial reaction in experimental proliferative vitreoretinopathy treated with liposomal doxorubicin.
Kuo HK; Chen YH; Wu PC; Wu YC; Huang F; Kuo CW; Lo LH; Shiea J
Invest Ophthalmol Vis Sci; 2012 Jun; 53(6):3167-74. PubMed ID: 22491400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
